Integral Derivatives’s Viatris VTRS Stock Holding History

Integral Derivatives’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,564	Closed	-$506K	–	1392
2016 Q4	$479K	Sell	12,564 -150	-1%	-$5.57K	0.01%	738
2016 Q3	$485K	Buy	+12,714	New	+$565K	0.01%	638
2015 Q4	–	Sell	-6,394	Closed	-$307K	–	1240
2015 Q3	$257K	Buy	+6,394	New	+$356K	0.01%	905

Other funds holding VTRS

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Integral Derivatives's VTRS Position: Q1 2017 in Review

Integral Derivatives sold out of Viatris (VTRS) in Q1 2017, closing a stake of 12,564 shares — an estimated $506K sold.

Integral Derivatives first reported a position in VTRS in Q3 2015 and held it in 3 quarters. The position peaked at $485K in Q3 2016. 568 funds tracked by Wall St. Rank hold VTRS as of Q1 2017.

Integral Derivatives reported no remaining Viatris position as of Q1 2017 after selling out during the quarter.
Integral Derivatives sold 12,564 Viatris shares in Q1 2017, an estimated $506K.
Integral Derivatives first reported a position in Viatris in Q3 2015 and held it in 3 quarters.
Integral Derivatives's Viatris position peaked at $485K in Q3 2016.
568 funds tracked by Wall St. Rank held Viatris as of Q1 2017.

Based on Integral Derivatives's 13F filing for Q1 2017, filed 15 May 2017.